News & Insights

High Court grants declaratory relief in pharmaceutical regulatory dispute

von Andrew Payne

The implementation of the Nagoya Protocol in Germany

von Verena Bertram

Upgrading the single market: updating the Bolar exemption

von Dr Paul England

Supreme Court ruling on penalty clauses: consequences for bad leaver provisions

von Debbie Cloake

Upgrading the single market: a unitary SPC?

von Dr Paul England

Facing up to antimicrobial resistance – recommendations from the O'Neill review

Largest damages award on cross-undertaking upheld on appeal

von Dr Paul England

Strategic considerations - why opt-out or why not?

von Dr. Anja Lunze, LL.M.

Pharmaceutical trade mark confusion